List view / Grid view
17 February 2015 | By GlobalData
Insomnia drug sales will fall rapidly from $2.1 billion in 2013 to $1.4 billion by 2016, before steadily recovering to $1.8 billion by 2023, driven by the launch of two products, Merck & Co.’s Belsomra and Eisai’s E-2006, and an increase in the prevalent cases of insomnia, says research and…
17 February 2015 | By Frost & Sullivan
New Frost & Sullivan Insights uncover the booming business potential for health services in 16 countries, among which Russia, Turkey, Kazakhstan, Greece, Bulgaria and the CIS...
17 February 2015 | By Public Health England
Public Health England (PHE) can confirm that a UK healthcare worker who had potential contact with the Ebola virus while working in Sierra Leone, is being transported to the UK for assessment and monitoring.
17 February 2015 | By Lucideon
Lucideon has launched iCRT-deter, a new delivery platform technology that provides abuse deterrent controlled release for pharmaceutical applications...
17 February 2015 | By Mundipharma
Mundipharma to provide supplies for at least two million handwashes in Ebola treatment centres...
17 February 2015 | By Biotie
COMP has issued a positive opinion recommending orphan drug designation for Biotie's BTT1023 for the treatment of primary sclerosing cholangitis (PSC)...
13 February 2015 | By Public Health England
Public Health England’s latest report shows a high number of scarlet fever notifications across England, with a total of 1265 new cases reported in the first 6 weeks of 2015...
13 February 2015 | By PatientView
An independent study by PatientView...
13 February 2015 | By Moberg Pharma
Moberg Pharma AB announced that it shipped opening orders of its new line extension, Kerasal® Complete Care in Walgreens, the #1 drug chain in the U.S., with additional retailers expected to follow...
Lonza, a global leader in biological and cell therapy manufacturing and TiGenix, an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from allogeneic expanded adipose-derived stem cells (eASCs) in inflammatory and autoimmune diseases, announced today an agreement for the supply of TiGenix's eASC product, Cx601.
12 February 2015 | By Equiniti 360 Clinical
The vast majority of patients are happy with the care they receive from their doctors, according to analysis by one of the UK’s largest providers of medical revalidation, Equiniti 360 Clinical, with over 98% saying they are satisfied with the overall experience provided...
12 February 2015 | By KU Leuven
Writing in the journal EBioMedicine, researchers at KU Leuven’s Laboratory for Clinical and Epidemiological Virology now report a recombinant form of HIV observed in patients in Cuba that makes this transition much faster...
11 February 2015 | By Eli Lilly & Company
College freshmen face tremendous pressure, often trying to adjust to tough academic standards while living away from home for the first time...
Amazing opportunities come along with prototyping technologies, and three-dimensional (3D) printing is gaining momentum across various industries, from printing a mobile phone cover to reconstructing human organs. Emerging as a technology of choice for a wide range of applications, 3D printing is expected to increase its market share rapidly to…
11 February 2015 | By GlobalData
Following a less than flattering financial performance in 2014, GlaxoSmithKline plc is realigning its operating structure with its corporate objectives and cashing in on its assets in the process, as the company seeks to drive up external investments and deliver stronger shareholder returns in the long term, says an analyst…
